Phio Pharmaceuticals Corp. - Common Stock — Quarterly Financial Statistics (NASDAQ:PHIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -1.27 M-2.54 M-2.08 M-2.08 M-4 M-4.04 M -12.2 M Cash from investing activities -2 000-3 000-7 00003 0000 -4 000 Cash from financing activities 9.17 M40 K2.02 M12.4 M00 14.43 M Free cash flow -1.27 M-2.54 M-2.08 M-2.08 M-4 M-4.04 M -12.2 M

News

What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday? - Phio Pharma (NASDAQ:PHIO)

Phio Pharmaceuticals stock soars after strong cancer treatment results

Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients - Phio Pharma (NASDAQ:PHIO)

Phio Pharmaceuticals reports 70% response rate in skin cancer trial

Phio to begin FDA-required toxicology study for cancer drug PH-762

Phio completes enrollment in Phase 1b trial of skin cancer therapy

Phio’s INTASYL PH-762 wins immunomodulatory solution of the year

3 Penny Stocks to Watch Now, 11/4/25 - TipRanks.com

Phio Pharmaceuticals raises $13.4 million through warrant exercise

Why Is Phio Pharmaceuticals Stock Soaring Today? - Phio Pharma (NASDAQ:PHIO)

Phio’s skin cancer treatment shows promising tumor clearance results

Phio Pharmaceuticals appoints David Deming as lead independent director